Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies
Public ClinicalTrials.gov record NCT02600351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed dose combination (FDC) for 12 weeks with or without ribavirin (RBV) in participants without cirrhosis, and LDV/SOF FDC for 12 weeks with RBV or LDV/SOF FDC for 24 weeks without RBV in participants with cirrhosis.
Study identification
- NCT ID
- NCT02600351
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2015 (Actual)
- Primary completion
- Mar 21, 2017 (Actual)
- Completion
- May 29, 2017 (Actual)
- Last update posted
- Nov 16, 2018
2015 – 2017
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | Rialto | California | 92377 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Ventura | California | 93003 | — |
| Not listed | New Haven | Connecticut | 06520 | — |
| Not listed | Largo | Florida | 33777 | — |
| Not listed | Weston | Florida | 33331 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Skokie | Illinois | 60076 | — |
| Not listed | Baltimore | Maryland | 21202 | — |
| Not listed | Columbia | Maryland | 21045 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Saint Paul | Minnesota | 55114 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Egg Harbor | New Jersey | 08234 | — |
| Not listed | New York | New York | 10025 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Charlotte | North Carolina | 28204 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Cleveland | Ohio | 44109 | — |
| Not listed | Columbus | Ohio | 43212 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Memphis | Tennessee | 38104 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Austin | Texas | 78758 | — |
| Not listed | Dallas | Texas | 75203 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02600351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02600351 live on ClinicalTrials.gov.